Rhythm Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Update

Go back to Rhythm Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Update
(NASDAQ: RYTM) Delayed: 96.79 +0.96 (1.00%)
Previous Close $95.83    52 Week High
Open $97.56    52 Week Low
Day High $99.89    P/E N/A 
Day Low $96.39    EPS
Volume 1,558,968